Resveratrol as a modulator of the gut-brain axis in irritable bowel syndrome
, , , , , , , und
08. Okt. 2024
Über diesen Artikel
Online veröffentlicht: 08. Okt. 2024
Seitenbereich: 68 - 72
Eingereicht: 02. Aug. 2024
Akzeptiert: 21. Sept. 2024
DOI: https://doi.org/10.2478/acb-2024-0010
Schlüsselwörter
© 2024 Bartosz Barzak et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Resveratrol, a polyphenolic compound synthesized by plants, has garnered increasing attention in recent years for its potential pharmacological applications. Notably, it has been explored as a modulator of the gut-brain axis, particularly concerning irritable bowel syndrome (IBS). IBS is a life-quality impairing condition characterized by recurrent abdominal pain associated with defecation, as well as alterations in stool frequency or form. This review provides a comprehensive overview of the role of the gut-brain axis in IBS, with a specific focus on the potential of resveratrol as a modulator of this axis and its therapeutic implications for IBS management.